Reduced foxp3 and interleukin 10 expression during the partial remission phase of type 1 diabetes in children

被引：0
|
作者：
Sanda, Srinath
Roep, Bart
von Herrath, Matthias
机构：
[1] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
[2] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands
[3] La Jolla Inst Allergy & Immunol, La Jolla, CA USA
来源：
CLINICAL IMMUNOLOGY | 2007年 / 123卷
关键词：
D O I：
10.1016/j.clim.2007.03.215
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S16 / S16
页数：1
相关论文
共 50 条
  • [21] Heterogeneity in IPEX Syndrome: A Foxp3 Mutation Causing Type 1 Diabetes without Enteropathy
    Cartwright, Bethany
    Grishman, Ellen
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 2): : 63 - 63
  • [22] Association of Foxp3 polymorphism with GAD65 autoantibodies in type 1 diabetes.
    Holm, Barbro
    Lindholm, Eero
    Lynch, Kristian
    Bakhatadze, Ekaterina
    Arvastsson, Jeanette
    Lernmark, Ake
    Agardh, Carl-David
    Cilio, Corrado
    CLINICAL IMMUNOLOGY, 2006, 119 : S169 - S169
  • [23] Interleukin 10 acts on regulatory T cells to maintain Foxp3 expression and suppressive function in mice with colitis.
    Murai, M.
    Kim, G.
    Madan, R.
    Karp, C.
    Cheroutre, H.
    Kronenberg, M.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S24 - S24
  • [24] Peptidase inhibitor 16 identifies a human regulatory T-cell subset with reduced FOXP3 expression over the first year of recent onset type 1 diabetes
    Hope, Christoper M.
    Welch, John
    Mohandas, Arunesh
    Pederson, Stephen
    Hill, Danika
    Gundsambuu, Batjargal
    Eastaff-Leung, Nicola
    Grosse, Randall
    Bresatz, Suzanne
    Ang, Grace
    Papademetrios, Michael
    Zola, Heddy
    Duhen, Thomas
    Campbell, Daniel
    Brown, Cheryl Y.
    Krumbiegel, Doreen
    Sadlon, Timothy
    Couper, Jennefer J.
    Barry, Simon C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 (08) : 1235 - 1250
  • [25] A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes
    Bassuny, WM
    Ihara, K
    Sasaki, Y
    Kuromaru, R
    Kohno, H
    Matsuura, N
    Hara, T
    IMMUNOGENETICS, 2003, 55 (03) : 149 - 156
  • [26] A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes
    Wafaa M. Bassuny
    Kenji Ihara
    Yuka Sasaki
    Ryuichi Kuromaru
    Hitoshi Kohno
    Nobuo Matsuura
    Toshiro Hara
    Immunogenetics, 2003, 55 : 149 - 156
  • [27] Effects of exogenous insulin on the activity of FOXP3 gene for patients with type 1 diabetes in Mosul city
    Ali, Saad Imrrer
    AL-Allaff, Rojan Ghanim
    MALAYSIAN JOURNAL OF MICROBIOLOGY, 2024, 20 (06) : 105 - 111
  • [28] The role of regulatory CD4+CD25+ T lymphocytes and FoxP3 expression in evolution and progression of type 1 diabetes
    Nikonova, T. V.
    Pekareva, E. V.
    Gorelysheva, V. A.
    Apanovich, P. V.
    Prokofyev, S. A.
    Dedov, I. I.
    DIABETOLOGIA, 2010, 53 : S181 - S182
  • [29] Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis
    Murai, Masako
    Turovskaya, Olga
    Kim, Gisen
    Madan, Rajat
    Karp, Christopher L.
    Cheroutre, Hilde
    Kronenberg, Mitchell
    NATURE IMMUNOLOGY, 2009, 10 (11) : 1178 - U61
  • [30] Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis
    Masako Murai
    Olga Turovskaya
    Gisen Kim
    Rajat Madan
    Christopher L Karp
    Hilde Cheroutre
    Mitchell Kronenberg
    Nature Immunology, 2009, 10 : 1178 - 1184
12345